Biotech · Private company
GeneOne Life Science, Inc.
Track this companyFree. Adds GeneOne Life Science, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials70 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- GLS-1027Phase 2 · PneumonitisClinicalTrials.gov · fetched Nov 12, 2026
- GLS-1200Phase 2 · SARS-CoV 2ClinicalTrials.gov · fetched Nov 12, 2026
- GLS-1200Phase 2 · Sinusitis ChronicClinicalTrials.gov · fetched Nov 12, 2026
- GLS-5300Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- GLS-5310 (Group 1)Phase 1 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- GLS-5310 (Group 2)Phase 1 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- GLS-5310 (Group 3)Phase 1 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- GLS-5310 (Group 4)Phase 1 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- GLS-5700Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- GLS-1200 Topical Nasal Spray to Prevent Sinusitis After Endoscopic Sinus SurgeryPHASE2 · UNKNOWN · started Dec 1, 2023ClinicalTrials.gov NCT04060316 · fetched Nov 12, 2026
- GLS-5310 Vaccine in Healthy Volunteers as a Booster for SARS-CoV-2 (COVID-19)PHASE1 · UNKNOWN · started May 23, 2022ClinicalTrials.gov NCT05182567 · fetched Nov 12, 2026
- GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19)PHASE2 · COMPLETED · started May 7, 2021ClinicalTrials.gov NCT04590547 · fetched Nov 12, 2026
- GLS-1200 Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19)PHASE2 · TERMINATED · started Jun 10, 2020ClinicalTrials.gov NCT04408183 · fetched Nov 12, 2026
- GLS-5700 in Dengue Virus-Naïve AdultsPHASE1 · COMPLETED · started Jul 1, 2016ClinicalTrials.gov NCT02809443 · fetched Nov 12, 2026
- Phase I, Open Label Dose Ranging Safety Study of GLS-5300 in Healthy VolunteersPHASE1 · COMPLETED · started Feb 1, 2016ClinicalTrials.gov NCT02670187 · fetched Nov 12, 2026
- Open-Label Study of INO-4212 With or Without INO-9012, Administered IM or ID Followed by Electroporation in Healthy VolunteersPHASE1 · COMPLETED · started May 1, 2015ClinicalTrials.gov NCT02464670 · fetched Nov 12, 2026